Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer

BACKGROUND: An important component of the RAS signalling pathway, the RAS p21 oncogene, is frequently hyperactivated in breast cancer. Its expression in tumor tissue has been linked to poor clinical outcome. This study was designed to evaluate the clinical relevance of RAS p21 levels in peripheral b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Banys-Paluchowski, Malgorzata, Fehm, Tanja, Janni, Wolfgang, Aktas, Bahriye, Fasching, Peter A., Kasimir-Bauer, Sabine, Milde-Langosch, Karin, Pantel, Klaus, Rack, Brigitte, Riethdorf, Sabine, Solomayer, Erich-Franz, Witzel, Isabell, Müller, Volkmar
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5941516/
https://ncbi.nlm.nih.gov/pubmed/29739347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4282-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados